A Product and Pipeline Analysis of the Global Haematology Therapeutics Market

An Overview of Promising Drugs and Innovations in the Haematology Therapeutics Market
Share this:
Published: 19 Mar 2013

This market insight provides the list of key marketed products as well key compounds in phase 2 and 3 clinical trials in the global nonmalignant blood disorders market, classified into eight major segments including antianaemics, anticoagulants, antifibrinolytics, fibrinolytics, blood substitutes, plasma expanders, platelet aggregation inhibitors, and other haematologicals. Additionally, an overview of the major on-going phase 3 clinical trials and detailed findings of most promising phase 3 compounds have also been provided.



Features of this research


Help Desk

Full list of offices

For more information and general enquiries, contact Frost & Sullivan near you.

North America
tel: +1.877.463.7678

Select a location near you..